A research team at the Helmholtz-Zentrum Dresden-Rossendorf (HZDR) has developed a radiopharmaceutical molecule marker that ...
As your surgeon alluded to, it’s more commonly found in hospitalized ill patients or residents in a long-term care facility ...
Dear A.K.: Ogilvie syndrome is acute pseudo-obstruction of the colon. It is considered pseudo-obstruction because it looks ...
The 'Shifting Gears' star reveals the skin cancer on his nose was 'missed five times' by his dermatologist before being ...
The First Annual Patrick Woepse Foundation Swim honored the life of the former UCLA water polo star, who died from a rare ...
India's lung cancer burden is projected to rise sharply by 2030, with the North-East emerging as the worst-affected region ...
LIXTE Biotechnology Holdings (NASDAQ: LIXT) announced an expansion of its collaboration with The University of Texas MD ...
Plans to seek regulatory approval to commence a Phase III trial in the US and Canada VANCOUVER, BC, Jan. 8, 2026 /PRNewswire/ -- Sustained Therapeutics Inc. ("Sustained Therapeutics" or the "Company") ...
New research presented at the 2025 International Kidney Cancer Symposium found that patients with localized renal cell ...
Alpenglow Biosciences, the leader in clinical-grade 3D digital pathology and AI-powered spatial analytics, and PathNet, one ...
Acrivon Therapeutics shares new trial data showing strong cancer responses, early tumor shrinkage, and pipeline progress, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback